Antibodies Market Growth Drivers, Strategies, Trends, and Forecast by 2031

Historic Data: 2021-2023   |   Base Year: 2024   |   Forecast Period: 2025-2031

Coverage: Antibodies Market covers analysis By Type (Monoclonal Antibodies, Polyclonal Antibodies, ADCs, Others); Technology (Western Blotting, Flow Cytometry, ELISA, Immunohistochemistry, Immunofluorescence, Immunoprecipitation, Others); Application (Proteomics, Drug Development, Genomics); End-User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, CRO's), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Date : Sep 2025
  • Report Code : TIPRE00005787
  • Category : Life Sciences
  • Status : Upcoming
  • Available Report Formats : pdf-format excel-format
  • No. of Pages : 150

MARKET OVERVIEW



Immunoglobulins (Ig) are another name for antibodies (Ab). These are big, Y-shaped proteins produced predominantly by plasma cells in the bloodstream in response to pathogens like viruses and bacteria. Antibodies have the ability to recognise specific molecules associated with hazardous substances. Antibodies are employed in the treatment of non-Hodgkin lymphoma, asthma, psoriasis, macular degeneration, rheumatoid arthritis, hypercholesterolemia, Crohn's disease, and as well as in the diagnosis of these diseases.

MARKET SCOPE



The "Global Antibodies Market Analysis to 2031" is a specialized and in-depth study of the biotechnology industry with a special focus on the global market trend analysis. The report aims to provide an overview of the antibodies market with detailed market segmentation by type, technology, application, end user, and geography. The report provides key statistics on the market status of the leading antibodies market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION



  •   Based on type, the market is bifurcated into monoclonal antibodies, polyclonal antibodies, ADCs, and others
  •   Based on technology, the market is bifurcated into western blotting, flow cytometry, elisa, immunohistochemistry, immunofluorescence, immunoprecipitation, and others
  •   Based on application, the market is bifurcated into proteomics, drug development, and genomics
  •   Based on end user, the market is bifurcated into pharmaceutical and biotechnology companies, academic and research institutes, and CRO's

MARKET DYNAMICS


Drivers:



  •   Increasing funding on R&D activities
  •   Growing industry-academia collaboration

Restraints:



  •   Quality concerns and a lack of reproducible results

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides market size and forecast estimates from the year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East and Africa (MEA), and South America. The antibodies market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.

The report analyzes factors affecting the market from both demand and supply side and further evaluates market dynamics affecting the marketduring the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South America after evaluating political, economic, social and technological factors affecting the antibodies market in these regions.

IMPACT OF COVID-19 ON ANTIBODIES MARKET



COVID-19 first began in Wuhan (China) during December 2019 and since then it has spread at a fast pace across the globe. The US, India, Brazil, Russia, France, the UK, Turkey, Italy, and Spain are some of the worst affected countries in terms confirmed cases and reported deaths. The COVID-19 has been affecting economies and industries in various countries due to lockdowns, travel bans, and business shutdowns. Shutdown of various plants and factories has affected the global supply chains and negatively impacted the manufacturing, delivery schedules, and sales of products in global market. Few companies have already announced possible delays in product deliveries and slump in future sales of their products. In addition to this, the global travel bans imposed by countries in Europe, Asia-Pacific, and North America are affecting the business collaborations and partnerships opportunities.

MARKET PLAYERS



The report covers key developments in the antibodies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the marketwere acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players. The market payers from antibodies market are anticipated to lucrative growth opportunities in the future with the rising demand for health coach in the global market.

The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the antibodies market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.

  •   Merck KGaA
  •   Cell Signaling Technology, Inc.
  •   BD
  •   F. Hoffmann-La Roche Ltd
  •   Bio-Rad Laboratories, Inc.
  •   Agilent Technologies, Inc.
  •   Beckman Coulter, Inc.
  •   GenScript
  •   QIAGEN
  •   Affinity Biologicals, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Antibodies Report Scope

Report Attribute Details
Market size in 2024 US$ XX million
Market Size by 2031 US$ XX Million
Global CAGR (2025 - 2031) 12.8%
Historical Data 2021-2023
Forecast period 2025-2031
Segments Covered By Type
  • Monoclonal Antibodies
  • Polyclonal Antibodies
  • ADCs
By Technology
  • Western Blotting
  • Flow Cytometry
  • ELISA
  • Immunohistochemistry
  • Immunofluorescence
  • Immunoprecipitation
By Application
  • Proteomics
  • Drug Development
  • Genomics
By End-User
  • Pharmaceutical and Biotechnology Companies
  • Academic and Research Institutes
  • CRO's
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Merck KGaA
  • Cell Signalling Technology, Inc.
  • BD
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories, Inc.
  • Agilent Technologies, Inc.
  • Beckman Coulter, Inc.
  • GenScript
  • QIAGEN

  • Frequently Asked Questions

    What are the options available for the customization of this report?

    Some of the customization options available based on request are additional 3-5 company profiles and country-specific analysis of 3-5 countries of your choice. Customizations are to be requested/discussed before making final order confirmation, as our team would review the same and check the feasibility.

    What are the deliverable formats of Antibodies Market report?

    The report can be delivered in PDF/PPT format; we can also share excel dataset based on the request.

    Which are the key players in the Antibodies Market?

    Key companies of this market are: Merck KGaA, Cell Signalling Technology Inc, BD, F Hoffmann La Roche Ltd, Bio Rad Laboratories Inc, Agilent Technologies Inc, Beckman Coulter Inc, GenScript, QIAGEN

    What are the future trends in the Antibodies Market?

    Key future trends in this market are - Growth of Monoclonal Antibodies, Rising Adoption in Diagnostics, Strategic Collaborations and Licensing Agreements

    What is the expected CAGR of the Antibodies Market?

    The Antibodies Market is estimated to witness a CAGR of 12.8% from 2023 to 2031.

    What are the driving factors impacting the Antibodies Market?

    The major factors driving the market are: Increasing Prevalence of Chronic Diseases, Innovation in Antibody Development, Government Funding and R&D Initiatives

    Mrinal Kerhalkar
    Mrinal Kerhalkar
    Manager,
    Market Research & Consulting

    Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

    Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset

    Testimonials

    Reason to Buy

    • Informed Decision-Making
    • Understanding Market Dynamics
    • Competitive Analysis
    • Identifying Emerging Markets
    • Customer Insights
    • Market Forecasts
    • Risk Mitigation
    • Boosting Operational Efficiency
    • Strategic Planning
    • Investment Justification
    • Tracking Industry Innovations
    • Aligning with Regulatory Trends
    Your Key Concerns Addressed - Question & Answer
    Can I view a sample of the report before purchasing?

    Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.

    Is analyst support included with the purchase?

    Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.

    What are the next steps once I place an order?

    Once your order is successfully placed, you will receive a confirmation email along with your invoice.

    • For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
    • For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.

    Can the report be tailored to suit my specific needs?

    We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.

    In what format is the report delivered?

    The report is available in either PDF format or as an Excel dataset, depending on the license you choose.

    The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
    Please review the license options at checkout or contact us to confirm which formats are included with your purchase.

    How secure is the payment process on your platform?

    Our payment process is fully secure and PCI-DSS compliant.

    We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
    You can make your purchase with confidence, knowing your personal and financial information is safe with us.

    Do you provide special pricing for buying multiple reports?

    Yes, we do offer special pricing for bulk purchases.
    If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.

    Can I connect with your team to discuss the report before buying?

    Yes, absolutely.
    Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.

    Will I get a billing invoice upon purchase?

    Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
    If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.

    Is there support available if I can’t access my report?

    Yes, certainly.
    If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.

    Our Clients
    The List of Companies

    1. Merck KGaA
    2. Cell Signalling Technology, Inc.
    3. BD
    4. F. Hoffmann-La Roche Ltd
    5. Bio-Rad Laboratories, Inc.
    6. Agilent Technologies, Inc.
    7. Beckman Coulter, Inc.
    8. GenScript
    9. QIAGEN
    10. Affinity Biologicals, Inc.
    11. BioLegend
    12. Lonza
    13. PerkinElmer
    14. Danaher Corporation
    15. Abcam Plc
    16. Thermo Fisher Scientific, Inc.
    Sales Assistance
    US: +1-646-491-9876
    UK: +44-20-8125-4005
    Email: sales@theinsightpartners.com
    Chat with us
    DUNS Logo
    87-673-9708
    ISO Certified Logo
    ISO 9001:2015
    ISO Certified Logo